| Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160) |
|---|
| 01/06/2005 | WO2005000800A1 Cathepsin cysteine protease inhibitors |
| 01/06/2005 | WO2005000799A1 Process for preparing polymorphic form (i) of modafinil |
| 01/06/2005 | WO2005000795A2 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators |
| 01/06/2005 | WO2005000794A1 Propionamide derivatives useful as androgen receptor modulators |
| 01/06/2005 | WO2005000242A2 Process for making polymorphic form a of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]butyric acid |
| 01/06/2005 | WO2004094650A3 Synthesis of labeled metabolites |
| 01/06/2005 | WO2004093800A3 Thyronamine derivatives and analogs and methods of use thereof |
| 01/06/2005 | US20050004212 Antitumor/cancer activity; topoisomerase I inhibitors |
| 01/06/2005 | US20050004192 Inhibiting virus's own RNA-dependent RNA polymerase, NS5B |
| 01/06/2005 | US20050004164 2-Cyanopropanoic acid amide and ester derivatives and methods of their use |
| 01/06/2005 | US20050004116 Triazole inhibitors of type 2 methionine aminopeptidase |
| 01/06/2005 | US20050004115 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 01/06/2005 | US20050002864 1,3-glyceride compound having two iodophenyl groups |
| 01/06/2005 | CA2530068A1 Cyanoalklamino derivatives useful as cathepsin cysteine protease inhibitors |
| 01/05/2005 | EP1494080A1 Azine-based dimeric charge transport materials |
| 01/05/2005 | EP1492774A2 Pyrimidone derivatives useful for the treatment of inflammation and immunological diseases |
| 01/05/2005 | EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives |
| 01/05/2005 | EP1492518A2 Tuberculosis treatment using pleuromutilin derivatives |
| 01/05/2005 | CN1561332A Preparation of HIV protease inhibitors |
| 01/05/2005 | CN1561331A Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1560034A Preparation process of organic selenium |
| 01/05/2005 | CN1183108C Method for improving mercapto phenol |
| 01/05/2005 | CN1183107C Alkynyl containing hydroxamic acid compounds as TACE inhibitors |
| 01/05/2005 | CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 01/05/2005 | CN1183075C Benzene derivative and its prepn. method |
| 01/04/2005 | US6838483 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 12/30/2004 | US20040267049 Hydrolyzing 5-(2-methylmercaptoethyl)hydantoin into metal salt of methionine via potassium hydroxides/carbonates, and bicarbonates, then neutralizing under pressure of carbon dioxide gas to crystallize |
| 12/30/2004 | US20040267042 Liquid phenolic sulphur-containing antioxidants |
| 12/30/2004 | US20040267041 Dissolving in ethanol and water; agitating suspension; cooling; isolation |
| 12/30/2004 | US20040267025 Compounds for the treatment of metabolic disorders |
| 12/30/2004 | US20040266879 Certain ethers of probucol, and their pharmaceutically acceptable salts or prodrugs, are useful for increasing circulating high density lipoprotein cholestrol |
| 12/30/2004 | US20040266789 Substituted amino carboxylic acids |
| 12/30/2004 | US20040266738 Fungicidal phenoxyphenylhydrazine derivatives |
| 12/30/2004 | US20040266684 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 12/30/2004 | US20040265717 Photoreceptor on electroconductive substrate; charge transfer and charge generating layers |
| 12/29/2004 | WO2004113285A1 Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid |
| 12/29/2004 | WO2004113284A1 Potassium or sodium salt of (-)-2-{`2-(4-hydroxyphenyl)ethyl!-thio-3-`4-(2-{4-`(methzlsulfonzl) oxy !phenoxy}phenyl!propanoic acid and their use in medicine |
| 12/29/2004 | WO2004113283A1 Amine salts of (-)-2-{`2-(4-hydroxyphenyl) ethyl!-thio}-3-`4-(2-{4-`(methylsulfonyl)oxy! phenoxy}ethyl)phenyl! propanoic acid and there use in medicine |
| 12/29/2004 | WO2004113282A1 Therapeutic agents |
| 12/29/2004 | WO2004113281A1 Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 12/29/2004 | WO2004113273A1 Pesticidally active ketone and oxime derivatives |
| 12/29/2004 | WO2004113270A2 Propionic acid derivatives useful in the treatment of lipid disorders |
| 12/29/2004 | WO2004089863A8 Process for the production of 2-hydroxy-4-methylthiobutyric acid ammonium salt |
| 12/29/2004 | WO2004063129A3 Methods for nucleophilic fluoromethylation |
| 12/29/2004 | WO2004043380A3 Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors |
| 12/29/2004 | WO2004002940A8 Inhibitors of hcv ns5b polymerase |
| 12/29/2004 | WO2002043648A3 Compounds active at the glucocorticoid receptor ii |
| 12/29/2004 | EP1491529A1 Phenolic compound and recording material containing the same |
| 12/29/2004 | EP1491190A1 Decomposition inhibitor for extracellular matrix of cartilage |
| 12/29/2004 | EP1490372A1 Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances |
| 12/29/2004 | EP1490331A2 Electron donors, electron acceptors and adhesion promoters containing disulfide |
| 12/29/2004 | EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | EP1259521B1 Method for preparing bismuth tris-trifluoromethanesulphonate |
| 12/29/2004 | EP1206442A4 Substituted chiral allosteric hemoglobin modifiers |
| 12/29/2004 | EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 12/29/2004 | CN1182116C Mutilin derivatives and their use as antibacterials |
| 12/29/2004 | CA2529544A1 Amine salts of (-)-2-{2-(4-hydroxyphenyl) ethyl!-thio}-3-4-(2-{4-(methylsulfonyl)oxy] phenoxy}ethyl)phenyl] propanoic acid and there use in medicine |
| 12/29/2004 | CA2529297A1 Therapeutic agents |
| 12/29/2004 | CA2529252A1 Process for the preparation of racemic 2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid |
| 12/29/2004 | CA2529251A1 Potassium or sodium salt of (-)-2-{[2-(4-hydroxyphenyl)ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid and their use in medicine |
| 12/29/2004 | CA2528234A1 Propionic acid derivatives useful in the treatment of lipid disorders |
| 12/28/2004 | US6835851 Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids |
| 12/28/2004 | US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 12/28/2004 | CA2236073C Intimal thickening inhibitory agent |
| 12/28/2004 | CA2126072C Tri-substituted phenyl derivatives and processes for their preparation |
| 12/23/2004 | WO2004111086A2 Peptide analogues comprising at least one type of aminoacyl aza-$g(b)3 and the use thereof, in particular for therapy |
| 12/23/2004 | WO2004111008A2 Use of a compound of formula i for making a pharmaceutical composition |
| 12/23/2004 | WO2004110974A1 Matrix metalloproteinase inhibitors |
| 12/23/2004 | WO2004110418A2 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/23/2004 | WO2004110339A2 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 12/23/2004 | WO2004099150A3 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 12/23/2004 | WO2003093250A3 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 12/23/2004 | US20040260088 Novel compounds |
| 12/23/2004 | US20040259950 Dicarboxy compounds for use as drugs and receptors for proliferation |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259891 Novel pyrimidon derivatives |
| 12/23/2004 | US20040259875 Incontinence; overactive bladder; neuropathic pain; neuralgia; analgesics; stroke; antiarthritic agents; antiinflammatory agents |
| 12/23/2004 | US20040256743 Replacing a halogen atom in organic compounds using as a catalyst a tris[tris(dialkylamino)- or tris(alkyleneamino)-phosphoranylideneamino]phosphine oxide or a phosphazenium derivative of the phosphine oxide |
| 12/23/2004 | US20040256616 Process of preparing a disubstituted 9-alkylidenefluorene or a derivative thereof |
| 12/23/2004 | CA2529486A1 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 12/23/2004 | CA2528003A1 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/22/2004 | EP1487430A1 Methods for treating diseases related to intraocular pressure |
| 12/22/2004 | EP1174028B1 Sulfonamide derivatives |
| 12/22/2004 | CN1556103A Novel synthesis technology of N-methyl-2-methyl-3-thia-5-chlorovaleryl amine |
| 12/22/2004 | CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same |
| 12/22/2004 | CN1181043C Quaternary bis-ammonium salt precursors and their uses as prodrugs having antiparasitic activity |
| 12/21/2004 | US6833382 Streptogramins and method for preparing same by mutasynthesis |
| 12/21/2004 | US6833140 Orally administered dosage forms of GABA analog prodrugs having reduced toxicity |
| 12/16/2004 | WO2004108663A1 N-alkynyl-2- (substituted aryloxy) alkylthioamide derivatives as fungicides |
| 12/16/2004 | WO2004108661A1 Amidino compounds as cysteine protease inhibitors |
| 12/16/2004 | WO2003063797A8 Cycloalkyl inhibitors of potassium channel function |
| 12/16/2004 | US20040254373 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 12/16/2004 | US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/16/2004 | US20040254240 Anti-cancer nitro- and thia-fatty acids |
| 12/16/2004 | US20040254237 Acid amide derivatives, process for producing these, and pest agent containing these |
| 12/16/2004 | US20040254222 Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 12/16/2004 | US20040254182 Enhanced propertied pharmaceuticals |
| 12/16/2004 | US20040253362 Comprising 1-mercapto-1-arylalkanes or derivatives thereof; add fruity, spicy and some tropical aspects to fruit flavour and vegetable compositions such as citrus, chilli and papaya |